West Pharmaceutical
755 hedge funds and large institutions have $25.8B invested in West Pharmaceutical in 2023 Q3 according to their latest regulatory filings, with 83 funds opening new positions, 243 increasing their positions, 302 reducing their positions, and 51 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
1% less capital invested
Capital invested by funds: $26B → $25.8B (-$209M)
10% less funds holding in top 10
Funds holding in top 10: 10 → 9 (-1)
20% less repeat investments, than reductions
Existing positions increased: 243 | Existing positions reduced: 302
Holders
755
Holding in Top 10
9
Calls
$89.2M
Puts
$72.9M
Top Buyers
| 1 | +$217M | |
| 2 | +$215M | |
| 3 | +$187M | |
| 4 |
GCM
Gladstone Capital Management
London,
United Kingdom
|
+$83.4M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$77.7M |
Top Sellers
| 1 | -$124M | |
| 2 | -$97M | |
| 3 | -$96.2M | |
| 4 |
Aberdeen Group
Edinburgh,
United Kingdom
|
-$89.4M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$77.6M |